Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine*

Depression is treated by a great variety of antidepressant treatments. SSRIs (such as fluoxetine) are well known: it is, however, sure that further progress is needed and the search for antidepressants with other mechanisms of action (such as tianeptine) or different efficacy is still of interest. A multinational study compared tianeptine with fluoxetine in 387 patients with Depressive Episode, or Recurrent Depressive Disorder, or Bipolar Affective Disorder (ICD-10), in a double-blind parallel group design. They were treated for six weeks. At inclusion, no significant difference between groups was shown. Final MADRS scores were 15.7 and 15.8 with tianeptine and fluoxetine, respectively (ITT population) (p = 0.944). MADRS responders were 58% and 56% with tianeptine and fluoxetine, respectively (p = 0.710). No statistical difference was observed for the other efficacy parameters. Thirty-six withdrawals occurred in each group, without any difference for the reasons of discontinuation. There was no major difference between groups for the other safety parameters. In this study, both tianeptine and fluoxetine exhibited a good efficacy and safety. Copyright 1999 Elsevier Science B. V. All rights reserved.

[1]  B. Renaud,et al.  Increased serotonin platelet uptake after tianeptine administration in depressed patients , 1991, Biological Psychiatry.

[2]  M. Abou-Saleh,et al.  Problems in validating endogenous depression in the Arab culture by contemporary diagnostic criteria. , 1997, Journal of affective disorders.

[3]  W. Strik,et al.  Number of symptoms, quantification, and qualification of depression. , 1996, Comprehensive psychiatry.

[4]  M. Rettori,et al.  Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. , 1988, Clinical neuropharmacology.

[5]  G. Kato,et al.  Neurochemical profile of tianeptine, a new antidepressant drug. , 1988, Clinical neuropharmacology.

[6]  A. Kamoun,et al.  Analysis of the side effects of tianeptine. , 1988, Clinical neuropharmacology.

[7]  H. Sternbach.  The serotonin syndrome. , 1991, The American journal of psychiatry.

[8]  Guelfi Jd.  Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview. , 1992 .

[9]  H. Lôo,et al.  Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients. , 1988, Neuropsychobiology.

[10]  J. Guelfi,et al.  Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice. , 1992, Neuropsychobiology.

[11]  J. Guelfi,et al.  Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. , 1989, Neuropsychobiology.

[12]  M. Chassaigne,et al.  Le système Am , 1972 .

[13]  J. Cabane,et al.  Efficacité de la tianeptine (Stablon®) dans le traitement des dépressions majeures et des dysthymies, avec plaintes somatiques. Etude comparée versus fluoxétine (Prozac®) , 1993 .

[14]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[15]  J. Guelfi,et al.  Long-Term Use of Tianeptine in 380 Depressed Patients , 1992, British Journal of Psychiatry.

[16]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[17]  A. Puech,et al.  Animal Behavioural Studies in the Evaluation of Antidepressant Drugs , 1992, British Journal of Psychiatry.

[18]  J. Michel,et al.  [Depression in elderly patients. Value of tianeptine in 140 patients treated for 1 year]. , 1991, Presse medicale.

[19]  W. Hiller,et al.  Evaluating the new ICD-10 categories of depressive episode and recurrent depressive disorder. , 1994, Journal of affective disorders.

[20]  M. Casacchia,et al.  The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline. , 1994, Neuropsychobiology.